Market Currents

• Thursday, November 6, 2008

• 15:10 PM Notable earnings after Thursday's close: AGO, ALKS, ANH, BBI, BYI, CAR, CBG, CEGE, CVTX, DAR, DIS, FLR, FTI, GNW, HANS, HGSI, IRF, MVSN, NDN, NKTR, NVDA, ONXX, PCLN, PDLI, PSA, PXP, QCOM, SAPE, SD, SWKS, TS, UTSI, VRSN Comment!
• 00:10 AM Notable earnings after Thursday's close: AGO, ALKS, ANH, BBI, BYI, CAR, CBG, CEGE, CVTX, DAR, DIS, FLR, FTI, GNW, HANS, HGSI, IRF, MVSN, NDN, NKTR, NVDA, ONXX, PCLN, PDLI, PSA, PXP, QCOM, SAPE, SD, SWKS, TS, UTSI, VRSN Comment!

• Wednesday, August 27, 2008

• 09:25 AM Cell Genesys (CEGE) stops its late-stage trial for prostate cancer therapy after 20 more deaths were reported in the group taking the drug versus the control group. Shares -75% pre-market. Comment!